Improved smoking cessation treatments and more research on e-cigarettes are urgently needed, according to the US National Institutes of Health (NIH) and Food and Drug Administration (FDA).
In a commentary published by the Annals of Internal Medicine, directors from the two agencies called for innovation in research and development of therapies aimed at supporting smokers who want to quit.
